At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Sentio 1device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of a Sound Processor for a Transcutaneous System
In Brief
A clinical study evaluating Sentio 1 for Conductive Hearing Loss and Mixed Hearing Loss. Completed, enrolled 11 participants across 1 site.
Detailed Summary
A single center study evaluating the performance of an externally worn sound processor for a transcutaneous bone anchored hearing system using audiological outcomes measures such as aided thresholds and self-evaluation questionnaires.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConductive Hearing Loss, Mixed Hearing Loss
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartNov 2022
First PostedNov 2022
Primary CompletionApr 2023
Study CompletionNov 2024
TodayJul 2026
First PostedNov 28, 2022
Enrollment StartNov 15, 2022
Primary CompletionApr 25, 2023
Study CompletionNov 15, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 3.6 years ago
Interventions
Sentio 1device
Sound processor